|
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
|
Feb 2014
|
Cancer
|
myelodysplastic syndromes (MDS)
|
|
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes
|
Mar 2016
|
Cancer
|
myelodysplastic syndromes (MDS)
|
|
Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
|
Jun 2014
|
Cell Stem Cell
|
myelodysplastic syndromes (MDS)
|
|
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
|
Oct 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up
|
Mar 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplantation in severe aplastic anemia
|
Jul 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients
|
Nov 2016
|
Haematologica
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes
|
Sep 2017
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
|
Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients
|
Feb 2015
|
Cancer Epidemiol
|
myelodysplastic syndromes (MDS)
|
|
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
|
Feb 2017
|
Mediterr J Hematol Infect Dis
|
myelodysplastic syndromes (MDS)
|
